| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Ah Equity Partners Bio I, L.l.c. last filed a Form 4 in October 2024, as 10% Owner at CAMP.
At the last filing, the largest reported position was 545,454 shares of CAMP. Net of sales, the CAMP filings show accumulation of 727,272 shares.
Ah Equity Partners Bio I, L.l.c. has 1 Form 4 filing on record in October 2024, as 10% Owner at Camp4 Therapeutics (CAMP), 2024.
The 3 reported transactions were 2 open-market purchases and 1 conversion.
Counted by filing, the open-market trades come to 1 purchase worth about $8.0M and no sales.
The only open-market purchase was 727,272 shares of CAMP at an average $11.00 on October 15, 2024, about $8.0M. Twelve months later CAMP was down 68%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | -400.0% | -63.3% | -68.0% |